EnWave (ENW) Q1 2026 earnings summary

Executive summary

• Q1 2026 revenue increased 36% year-over-year to CAD 1.6 million, driven by higher royalties, tooling revenue, and large-scale machine sales.

• Signed three new license agreements, expanding into snacking, cannabis, and tropical produce markets, including deals with BGGA (Australia), Shinyway International (New Zealand), and a U.S. snack company.

• Commissioned one large-scale machine and completed fabrication of two more on contract during the quarter.

• Commercial pipeline remains robust, with active engagement across North America, Europe, and emerging markets.

• Focused on scaling recurring royalty revenue and supporting partners' capacity expansions.

Financial highlights

• Q1 2026 revenue was CAD 1.6 million, up from CAD 1.2 million in Q1 2025.

• Base royalties rose 18% to CAD 500K; total royalty revenue (including exclusivity) up 12% to CAD 627K.

• Gross margin improved to 37% from 29% year-over-year, attributed to higher royalties and favorable production mix.

• SG&A (including R&D) increased 16% to CAD 1.5 million, reflecting higher sales personnel and professional fees.

• Adjusted EBITDA loss narrowed to CAD 585K from CAD 635K year-over-year.

• Net loss from continuing operations was CAD 1.108 million, up 18% year-over-year; loss per share was $(0.01).

• Cash and equivalents at quarter-end were CAD 2.5 million; net working capital surplus of CAD 8.5 million.

Outlook and guidance

• Confident in achieving targeted royalty collections of CAD 2.3 million for fiscal 2026.

• Multiple advanced-stage machine evaluations and license opportunities expected to convert in coming quarters.

• Focus on high-margin verticals such as pet treats, functional ingredients, and premium snacks.

• No immediate need for further financings anticipated, with inventory investments expected to convert to cash.

• Ongoing strategy to expand royalty-bearing commercial licenses and grow market presence in food, pharmaceutical, and cannabis sectors.